Pharmacokinetics, safety, activity, and biomarker analysis of palbociclib plus letrozole as first-line treatment for ER+/HER2- advanced breast cancer in Chinese women.
Autor: | Xu, Binghe, Li, Huiping, Zhang, Qingyuan, Sun, Wan, Yu, Yanke, Li, Wei, Wang, Shusen, Liao, Ning, Shen, Peng, Liu, Yuan, Huang, Yaling, Linn, Carlos, Zhao, Huadong, Jiang, John, Wang, Diane |
---|---|
Předmět: |
BREAST cancer
BIOMARKERS TERIPARATIDE EPIDERMAL growth factor receptors PHARMACOKINETICS RETINOBLASTOMA protein PROTEIN metabolism THERAPEUTIC use of antineoplastic agents PYRIDINE RESEARCH CLINICAL trials HETEROCYCLIC compounds RESEARCH methodology ANTINEOPLASTIC agents CELL receptors MEDICAL cooperation EVALUATION research TREATMENT effectiveness COMPARATIVE studies POSTMENOPAUSE BREAST tumors |
Zdroj: | Cancer Chemotherapy & Pharmacology; Jul2021, Vol. 88 Issue 1, p131-141, 11p |
Abstrakt: | |
Databáze: | Complementary Index |
Externí odkaz: |